176 related articles for article (PubMed ID: 38166947)
21. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
Yin H; Sheng Z; Zhang X; Du Y; Qin C; Liu H; Dun Y; Wang Q; Jin C; Zhao Y; Xu T
Oncol Rep; 2017 Feb; 37(2):1045-1051. PubMed ID: 27922675
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
24. m
Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
[TBL] [Abstract][Full Text] [Related]
25. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.
Zhang Q; Yang Z; Jia Z; Liu C; Guo C; Lu H; Chen P; Ma K; Wang W; Zhou C
Mol Cancer; 2014 Jul; 13():181. PubMed ID: 25070240
[TBL] [Abstract][Full Text] [Related]
26.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
27. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
[TBL] [Abstract][Full Text] [Related]
28. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
[TBL] [Abstract][Full Text] [Related]
29. IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway.
Zheng T; Ma G; Tang M; Li Z; Xu R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591689
[TBL] [Abstract][Full Text] [Related]
30. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
31. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
32. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
33. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
34. GREM1 knockdown regulates the proliferation, apoptosis and EMT of benign prostatic hyperplasia by suppressing the STAT3/c-Myc signaling.
Sun X; Jiang M; Wang Z; Xu C; Ma Z
Tissue Cell; 2024 Feb; 86():102231. PubMed ID: 37931534
[TBL] [Abstract][Full Text] [Related]
35. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells.
Kidder BL; Yang J; Palmer S
PLoS One; 2008; 3(12):e3932. PubMed ID: 19079543
[TBL] [Abstract][Full Text] [Related]
36. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
[TBL] [Abstract][Full Text] [Related]
37. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
[TBL] [Abstract][Full Text] [Related]
38. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
40. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
